Viewing nowCombinationEmpagliflozin/Metformin Hydrochloride Tablet 5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.

MFDS item code 202501727 · Approved 2025.07.09 · Insurance code 642907070
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication effectively improves blood sugar levels in adult patients with type 2 diabetes who have insufficient blood sugar control despite dietary and exercise therapies, using both empagliflozin and metformin as active components. It can also be administered to patients with cardiovascular diseases. For information regarding the occurrence of cardiovascular events, please refer to professional guidelines. This medication is used as a therapeutic agent to aid in the management of blood sugar levels in type 2 diabetes patients.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication helps regulate blood sugar levels. Serious side effects such as lactic acidosis may occur while taking this medication, so caution is advised. Lactic acidosis is a condition arising from an excessive accumulation of lactic acid in the body, with symptoms including fatigue, muscle pain, difficulty breathing, abdominal pain, etc. Furthermore, if this medication is taken with other antidiabetic agents, there is a risk of hypoglycemia, so blood sugar changes should be closely monitored. Patients with decreased kidney function or severe kidney disease should not take this medication. It should also be avoided in cases of acute infections, dehydration, heart problems, severe trauma, or liver dysfunction as risks may arise. Before and after undergoing examinations with iodinated contrast agents, temporarily discontinuing this medication is necessary, and it should not be resumed until kidney function is confirmed to be normal after the examination. Women who are pregnant or breastfeeding should not take this medication, and women who may become pregnant should consult prior to use. This medication may lead to fluid loss, so caution is warranted in cases of dehydration, diarrhea, or vomiting. Regular checks of kidney function, including serum creatinine levels, should be done during treatment, especially in the elderly who should be particularly cautious about kidney function. This medication may increase the risk of genital and urinary tract infections, so consult a doctor immediately if symptoms of infection arise. Vitamin B12 levels may decrease with long-term use, so regular blood tests are recommended. Alcohol consumption can increase the risk of lactic acidosis, so avoid excessive drinking while using this medication. No special effects have been reported concerning driving or operating machinery, but caution should be exercised as hypoglycemic symptoms may occur. Regular blood sugar and kidney function tests are necessary during treatment, and if unusual symptoms occur, consult a doctor promptly. In the event of an overdose, immediate medical attention is required, and blood dialysis may be necessary.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture, at room temperatures between 1 to 30 degrees Celsius. This will help maintain the efficacy of the medication over time.
Orange-yellow, biconvex, oval film-coated tablet
60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.